Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Goebel

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Atherosclerosis|April 13, 2018
Circulating Wnt inhibitory factor 1 levels are associated with development of cardiovascular diseaseClaudia Ress, Mariya Paulweber, Georg Goebel, et al.
Parkinsonism & Related Disorders|February 22, 2018
Diagnostic potential of dentatorubrothalamic tract analysis in progressive supranuclear palsyMorinobu Seki, Klaus Seppi, Christoph Mueller, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|April 17, 2024
Sex-related differences in the clinical presentation of multiple system atrophyFabian Leys, Sabine Eschlböck, Nicole Campese, et al.
BMJ Open|May 28, 2025
Protocol for olfactory training in persisting COVID-19-associated loss of smell (SMELL): a monocentric randomised controlled trial conducted in InnsbruckNicolas De Cleene, Frank Jagusch, Joachim Schmutzhard, et al.
Journal of Parkinson'S Disease|August 28, 2019
Diagnostic Potential of Multimodal MRI Markers in Atypical Parkinsonian DisordersMorinobu Seki, Klaus Seppi, Christoph Mueller, et al.
Oncogene|March 30, 2004
Cyclin E dysregulation and chromosomal instability in endometrial cancerMichael M Hubalek, Andreas Widschwendter, Martin Erdel, et al.
Neurology|January 23, 2015
Olfactory dysfunction predicts early transition to a Lewy body disease in idiopathic RBDPhilipp Mahlknecht, Alex Iranzo, Birgit Högl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
Methylated NEUROD1 promoter is a marker for chemosensitivity in breast cancerHeidi Fiegl, Allison Jones, Cornelia Hauser-Kronberger, et al.
BMJ Open|May 1, 2024
Effects of physiotherapy and home-based training in parkinsonian syndromes: protocol for a randomised controlled trial (MobilityAPP)Cecilia Raccagni, Victoria Sidoroff, Anisoara Paraschiv-Ionescu, et al.
Movement Disorders Clinical Practice|April 25, 2024
Early Screening for the Parkinson Variant of Multiple System Atrophy: A 6-Item ScoreAlessandra Fanciulli, Iva Stankovic, Omer Avraham, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Atherosclerosis|April 13, 2018
Circulating Wnt inhibitory factor 1 levels are associated with development of cardiovascular diseaseClaudia Ress, Mariya Paulweber, Georg Goebel, et al.
Parkinsonism & Related Disorders|February 22, 2018
Diagnostic potential of dentatorubrothalamic tract analysis in progressive supranuclear palsyMorinobu Seki, Klaus Seppi, Christoph Mueller, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|April 17, 2024
Sex-related differences in the clinical presentation of multiple system atrophyFabian Leys, Sabine Eschlböck, Nicole Campese, et al.
BMJ Open|May 28, 2025
Protocol for olfactory training in persisting COVID-19-associated loss of smell (SMELL): a monocentric randomised controlled trial conducted in InnsbruckNicolas De Cleene, Frank Jagusch, Joachim Schmutzhard, et al.
Journal of Parkinson'S Disease|August 28, 2019
Diagnostic Potential of Multimodal MRI Markers in Atypical Parkinsonian DisordersMorinobu Seki, Klaus Seppi, Christoph Mueller, et al.
Oncogene|March 30, 2004
Cyclin E dysregulation and chromosomal instability in endometrial cancerMichael M Hubalek, Andreas Widschwendter, Martin Erdel, et al.
Neurology|January 23, 2015
Olfactory dysfunction predicts early transition to a Lewy body disease in idiopathic RBDPhilipp Mahlknecht, Alex Iranzo, Birgit Högl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
Methylated NEUROD1 promoter is a marker for chemosensitivity in breast cancerHeidi Fiegl, Allison Jones, Cornelia Hauser-Kronberger, et al.
BMJ Open|May 1, 2024
Effects of physiotherapy and home-based training in parkinsonian syndromes: protocol for a randomised controlled trial (MobilityAPP)Cecilia Raccagni, Victoria Sidoroff, Anisoara Paraschiv-Ionescu, et al.
Movement Disorders Clinical Practice|April 25, 2024
Early Screening for the Parkinson Variant of Multiple System Atrophy: A 6-Item ScoreAlessandra Fanciulli, Iva Stankovic, Omer Avraham, et al.
Pageof 8